AksharChem (I)Q3 FY18

AksharChem (I) Q3 FY18 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹414.7P/E: 26.9Market Cap: ₹333 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • The company expects an additional revenue of approximately Rs.250 Crores from expansions over the next two years.
  • Incremental revenue breakdown:
  • - H acid expansion: ~Rs.50 Crores, expected to contribute from FY2019.
  • - CPC Green expansion: ~Rs.100 Crores, expected mostly in FY2020.
  • - Silica expansion: ~Rs.100 Crores, expected from Q1 FY2020.
  • Current planning targets around 80% capacity utilization within two years, with potential to reach 90% later.
  • Vinyl Sulphone and CPC Green volumes grew by 10% in nine months FY2018 and 25% in Q3 FY2018 year-on-year.
  • New Violet 23 pigment sales are anticipated to start from Q1 FY2019.
  • Overall volume growth is forecasted at around 11% aligned with industry expectations.
  • The company expects improved revenue and utilization post capacity expansions, gradually increasing revenue growth.

See what AksharChem (I) management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes
  • Currently, the company has zero debt.
  • They have raised funds through a Qualified Institutional Placement (QIP).
  • They plan to take debt of around Rs. 30-40 Crores towards the closing part of the ongoing capex project.
  • The timing of this debt is expected near project completion; no debt is planned immediately.
  • They are considering both foreign currency loans and Indian rupee loans depending on the most favorable option at that time.
  • Foreign currency loans, if taken, could be offset against exports, reducing currency risk.
  • No immediate equity fundraising mentioned beyond the QIP already completed.

See what AksharChem (I) management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Ongoing expansions include CPC Green (480 tonnes per annum), Silica, and H Acid projects.
  • Expected incremental revenues from expansions: Rs.50 Crores from H Acid, Rs.100 Crores from Green expansion, Rs.100 Crores from Silica.
  • H Acid expansion revenue to start contributing from Q1 FY2019.
  • Silica expansion revenue expected from Q1 FY2020.
  • CPC Green second phase expansion to complete in next 12 months.
  • Violet 23 pigment plant commenced trial production; expected sales from Q1 FY2019.
  • CPC Blue project is underway for captive consumption but will not contribute to revenues.
  • Total new capex incremental revenue expected around Rs.250 Crores, with Rs.50 Crores in FY2019 and Rs.200 Crores in FY2020.
  • Debt planned to support capex around Rs.30-40 Crores, undecided on foreign currency or rupee loans.
  • Capex expected to complete within next 12 months.

Track AksharChem (I) — get its next earnings analysis in your feed

How does AksharChem (I) rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisAksharChem (I)
Rev 3Mar 3

How does AksharChem (I) rank in Chemicals & Petrochemicals?

Compare AksharChem (I) against every Chemicals & Petrochemicals company (Q3 FY18) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • GOCL Corporation Ltd (Q2 FY27)

    Year-on-year (YoY) increase in revenue from operations: Approximately 85% increase (41,063 vs. Key results statement takeaways from GOCL Corpn.'s Q2 FY27 result

  • Bhansali Engineering Polymers Ltd (Q2 FY27)

    Revenue from operations (net) for the quarter ended 30/09/2026 is ₹40,336.95 lakhs, compared to ₹32,509.76 lakhs for the quarter ended 30/09/2025, reflecting a…

  • Tatva Chintan (Q2 FY27)

    Q2 FY27 revenue from operations: ₹2,173 Mn, up 76% YoY from ₹1,235 Mn in Q2 FY26 (Page 11). Key investor presentation takeaways from Tatva Chintan's Q2 FY27 inv

  • Devson Catalyst Ltd (Q1 FY27)

    FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →